Additional Details

  • DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

    Legacy Research Institute
    Portland OR. 97210
    View Details

  • DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

    AnMed Health
    Anderson SC. 29621
    View Details

  • DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

    Pulmonary Associates of Richmond, Inc.
    Richmond VA. 23230
    View Details

  • A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis

    UCLA Health Westwood Medical Plaza
    Westwood CA. 90095
    View Details

  • A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis

    Institut universitaire de cardiologie et de pneumologie de Québec-Université Laval
    Québec QC. G1V4G5
    View Details

  • A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis

    The Pennsylvania State University
    Hershey PA. 17033
    View Details

  • A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis

    University of Utah Health
    Salt Lake City UT. 84108
    View Details

  • A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis

    Loyola University Medical Center
    Maywood IL. 60153
    View Details

  • A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis

    Beth Israel Deaconess Medical Center
    Boston MA. 02215
    View Details

  • A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis

    Cedars-Sinai
    Los Angeles CA. 90048
    View Details

  • A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis

    Endeavor Health
    Evanston IL. 60201
    View Details

  • A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis

    Yale University
    New Haven CT. 06519
    View Details

  • A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis

    The University of Texas Health Science Center
    Houston TX. 77030
    View Details

  • A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis

    Baylor Scott & White Research Institute, Baylor University Medical Center
    Dallas TX. 75246
    View Details

  • A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis

    Columbia University
    New York NY. 10032
    View Details

  • A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis

    University of Washington
    Seattle WA. 98195
    View Details

  • A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis

    Baylor College of Medicine
    Houston TX. 77030
    View Details

  • A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis

    Research Institute McGill University Health Center
    Montreal QC. H4A 3J1
    View Details

  • A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis

    University of Southern California
    Los Angeles CA. 90033
    View Details

  • A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis

    Intermountain Medical Center
    Murray UT. 84157
    View Details